MANAGEMENT OF MYASTHENIA GRAVIS IN THE OBSTETRICAL PATIENT.
D000549:Ambenonium Chloride; D002800:Cholinesterase Inhibitors; D003933:Diagnosis; D004358:Drug Therapy; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases; D009157:Myasthenia Gravis; D009388:Neostigmine; D009468:Neuromuscular Diseases; D011247:Pregnancy; D011248:Pregnancy Complications; D011729:Pyridostigmine Bromide
D002800:Cholinesterase Inhibitors; D009388:Neostigmine; D000549:Ambenonium Chloride; D011729:Pyridostigmine Bromide
AMBENONIUM CHLORIDE; AMYOTONIA CONGENITA; CHOLINESTERASE INHIBITORS; DIAGNOSIS; DRUG THERAPY; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; MYASTHENIA GRAVIS; NEOSTIGMINE; PREGNANCY; PREGNANCY COMPLICATIONS; PYRIDOSTIGMINE BROMIDE